Interventional Treatment for Giant Hepatic Hemangioma Accompanied by Arterio-portal Shunt with Ascites

Intern Med. 2018 Oct 1;57(19):2847-2851. doi: 10.2169/internalmedicine.0655-17. Epub 2018 Apr 27.

Abstract

A 73-year-old woman with massive ascites associated with a giant hepatic mass accompanied by arterio-portal (AP) shunt was admitted to our hospital. Based on contrast-enhanced computed tomography (CT) and angiography findings, hepatic hemangioma with AP shunt and ascites due to portal hypertension was diagnosed. Transcatheter arterial embolization (TAE) by N-butyl-2-cyanoacrylate (NBCA) was performed without complications. The patient's ascites disappeared, and her liver function test results improved after the treatment. The patient has maintained a steady state for two years. This case indicates that TAE with NBCA is a safe and effective treatment for hepatic hemangioma accompanied by AP shunt.

Keywords: N-butyl-2-cyanoacrylate; arterio-portal shunt; ascites; hepatic hemangioma; portal hypertension; transcatheter arterial embolization.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angiography
  • Ascites / diagnosis
  • Ascites / etiology
  • Ascites / therapy*
  • Contrast Media
  • Embolization, Therapeutic*
  • Enbucrilate / therapeutic use
  • Female
  • Hemangioma / complications
  • Hemangioma / diagnosis
  • Hemangioma / therapy*
  • Humans
  • Hypertension, Portal / complications
  • Hypertension, Portal / diagnosis
  • Hypertension, Portal / therapy*
  • Liver Neoplasms / complications
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / therapy*
  • Tomography, X-Ray Computed

Substances

  • Contrast Media
  • Enbucrilate